Dune Medical Devices

Real-time Cancer Detection

Health Tech & Life Sciences
Acquired (Inactive) by Dilon Technologies on Apr 2020 - closed due to acquisition

Company Overview

Snapshot

Founded in January 2002 by Dan Hashimshony, Dune Medical Devices operated with 11–50 employees. The company raised a total of $53.8M across 6 funding rounds from 5 investors. Dune Medical Devices was acquired by Dilon Technologies in April 2020.

Business overview

Dune Medical Devices specializes in developing tissue characterization technology for real-time cancer detection, primarily serving surgeons and radiologists. Its core product, the MarginProbe System, utilizes a Fringe Field Sensor to assess excised tissue margins during surgery, particularly for breast cancer. The company was also developing a smart biopsy system for breast tissue, expanding its surgical oncology portfolio. Dune Medical Devices operates within the Health Tech & Life Sciences sector, focusing on medical devices and diagnostics.

Strategic signal

In April 2020, Dune Medical Devices was acquired by Dilon Technologies. This acquisition signifies a strategic consolidation within the medical device industry, integrating Dune Medical's real-time cancer detection technology into a larger portfolio and potentially expanding its market reach and application.

Company Intelligence Q&A

When was Dune Medical Devices acquired?
Dune Medical Devices was acquired by Dilon Technologies in April 2020.
What is the primary function of the MarginProbe System?
The MarginProbe System provides real-time cancer detection in the operating room by assessing the margin of excised tissue using a Fringe Field Sensor.
What was Dune Medical Devices developing with support from the European Union?
Dune Medical Devices was developing a smart biopsy system for breast tissue, which received funding from the European Union's Horizon 2020 research and innovation program.
Which investors participated in the July 2017 funding round?
In July 2017, Dune Medical Devices received funding from Canepa Healthcare and The Kraft Group.
Which investor led the October 2014 funding round?
Apax Partners led a funding round for Dune Medical Devices in October 2014, with participation from.

External links